Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach

Journal of Pharmaceutical Sciences

Volumn 88, Issue 5, 1999, Pages 515-522

  Roberts, William J ^a   Sloan, Kenneth B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MERCAPTOPURINE; PRODRUG; THEOPHYLLINE;

AQUEOUS SOLUTION; ARTICLE; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; LIPID SOLUBILITY; MATHEMATICAL MODEL; MOLECULAR WEIGHT; PARTITION COEFFICIENT;

EID: 0032897090     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980419b     Document Type: Article

References (32)

1. Sloan, K. B. Functional group considerations in the development of prodrug approaches to solving topical delivery problems. In Prodrugs: Topical and Ocular Drug Delivery; Sloan, K. B., Ed.; Marcel Dekker: New York, 1992; pp 17-116.
2. Sloan, K. B.; Getz, J. J.; Beall, H. D.; Prankerd, R. J. Transdermal of 5-fluorouracil (5-FU) by 1-alkylaminocarbonyl-5-FU prodrugs through hairless mouse skin: physicochemical characterization of prodrugs and correlations with transdermal delivery. Int. J. Pharm. 1993, 93, 27-36.
3. Beall, H. D.; Prankerd, R. J.; Sloan, K. B. Transdermal delivery of 5-fluorouracil (5-FU) through hairless mouse skin by 1-alkyloxycarbonyl-5-FU prodrugs: physicochemical characterization of prodrugs and correlations with transdermal delivery. Int. J. Pharm. 1994, 111, 223-233.
4. Beall, H. D.; Sloan, K. B. Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs. Int. J. Pharm. 1996, 729, 203-210.
5. Taylor, H. E.; Sloan, K. B. 1-Alkylcarbonyloxymethyl Prodrugs of 5-Fluorouracil (5-FU): Synthesis, Physicochemical Properties and Topical Delivery of 5-FU. J. Pharm. Sci. 1998, 87, 15-20.
6. Waranis, R. P.; Sloan, K. B. The effect of vehicle and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: bisacyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 1987, 76, 587-595.
7. 6-acyloxymethyl-6-mercaptopurine prodrugs. J. Pharm. Sci. 1988, 77, 210-215.
8. Kerr, D. P.; Roberts, W. J.; Tebbett, I. R.; Sloan, K. B. 7-Alkylcarbonyloxymethyl prodrugs of theophylline: topical delivery of theophylline. Int. J. Pharm. 1998, 167, 37-48.
9. Baker, D. C.; Kumar, S. D.; Waites, W. J.; Arnett, G.; Shannon, W. M.; Higuchi, W. I.; Lambert, W. J. Synthesis and Evaluation of a Series of 2′-O-Acyl Derivatives of 9-β-D-Arabinofuranosyladenine as Antiherpes Agents. J. Med. Chem. 1984, 27, 270-274.
10. Shannon, W. M.; Arnett, G.; Baker, D. C.; Kumar, S. D.; Higuchi, W. I. Evaluation of prodrugs of 9-β-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs. Antimicrob. Agents Chemother. 1983, 24, 706-712.
11. Friend, D.; Catz, P.; Heller, T.; Reid, J., Baker, R. Transdermal delivery of levonorgestrel II: effect of prodrug structure on skin permeability in vitro. J. Controlled Release 1988, 7, 251-261.
12. Bonina, F. R.; Montenegro, L.; DeCapraris, P.; Bousquet, E.; Tirendi, S. 1-Alkylazacycloalkane-2-one esters as prodrugs of indomethacin for improved delivery through human skin. Int. J. Pharm. 1991, 77, 21-29.
13. Potts, R. O.; Guy, R. H. Predicting skin permeability. Pharm. Res. 1992, 9, 663-669.
14. Kasting, G. B.; Smith, R. L.; Cooper, E. R. Effect of lipid solubility and molecular size on percutaneous absorption. In Skin Pharmokinetics; Shroot, B., Schaefer, H., Eds.; Karger: Basel, 1987; pp 138-153.
15. Scheuplein, R. J.; Blank, I. H. Molecular structure and diffusional processes across intact skin. Report to the U. S. Army Chemical R and D Laboratories: Edgewood Arsenal, MD, 1967.
16. Roberts, M. S.; Anderson, R. A.; Swarbrick, J. Permeability of human epidermis to phenolic compounds. J. Pharm. Pharmacol. 1977, 29, 677-683.
17. Ackerman, C.; Flynn, G. L.; Smith, W. M. Ether-water partitioning and permeability through hairless mouse skin in vitro. II. Hydrocortisone 21-n-alkyl esters, alkanols and hydrophilic compounds. Int. J. Pharm. 1987, 36, 67-71.
18. Flynn, G. L. Physicochemical determinants of skin absorption. In Principles of Route-to-Route Extrapolation for Risk Assessment; Gerrity, T. R., Henry, C. J., Eds; Elsevier: New York, 1990; pp 93-127.
19. Abraham, M. H.; Chadha, H. S.; Mitchell, R. C. The factors that influence skin penetration of solutes. J. Pharm. Pharmacol. 1995, 47, 8-16.
20. Potts, R. O.; Guy, R. H. A predictive algorithm for skin permeability: the effect of molecular size and hydrogen bond activity. Pharm. Res. 1995, 12, 1628-1633.
21. Roberts, M. S.; Pugh, W. J.; Hadgraft, J.; Watkinson, A. C. Epidermal permeability-penetrant structure relationships: 1. An analysis of methods of predicting penetration of monofunctional solutes from aqueous solutions. Int. J. Pharm. 1995, 126, 219-233.
22. Pugh, W. J.; Roberts, M. S.; Hadgraft, J. Epidermal permeability-penetrant structure relationship: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int. J. Pharm. 1996, 138, 149-165.
23. Surber, C.; Wilhelm, K. P.; Hori, M.; Maibach, H. I.; Guy, R. H. Optimization of topical therapy: partitioning of drugs into stratum corneum. Pharm. Res. 1990, 7, 1320-1324.
24. Diamond, J. M.; Katz, Y. Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water. J. Membr. Biol. 1974, 17, 127-154.
25. Sasaki, H.; Takahashi, T.; Mori, Y.; Nakamura, J ; Shibasaki, J. Transdermal delivery of 5-fluorouracil and its alkylcarbamoyl derivatives. Int. J. Pharm. 1990, 60, 1-9.
26. Barton, A. F. M. Solubility Parameters. Chem. Rev. 1975, 75, 731-753.
27. Leron, Z.; Cohen, S. Percutaneous absorption of alkanoic acids II. Application of regular solution theory. J. Pharm. Sci. 1984, 73, 538-542.
28. Sherertz, E. F.; Sloan, K. B.; McTiernan, R. G. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulation and a prodrug. Arch. Dermatol. Res. 1990, 282, 463-468.
29. Sloan, K. B.; Koch, S. A. M.; Siver, K. G.; Flowers, R. P. Use of solubility parameters of drug and vehicle to predict flux through skin. J. Invest. Dermatol. 1986, 87, 244-252.
30. Sherertz, E. F.; Sloan, K. B.; McTiernan, R. G. Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J. Invest. Dermatol. 1987, 89, 147-151.
31. Waranis, R. P.; Siver, K. G.; Sloan, K. B. The solubility parameter of vehicles as a predictor of relative vehicle effects on the diffusion of 6-mercaptopurine. Int. J. Pharm. 1987, 36, 211-222.
32. Buur, A.; Trier, L.; Magnusson, C.; Artursson, P. Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers. Int. J. Pharm. 1996, 129, 223-231.